Public Profile

InterCure Ltd.

InterCure Ltd., a leading player in the medical cannabis industry, is headquartered in Israel (IL) and operates extensively across Europe and North America. Founded in 2010, the company has achieved significant milestones, establishing itself as a pioneer in the cultivation and distribution of high-quality cannabis products. InterCure focuses on developing innovative therapeutic solutions, offering a range of unique cannabis-based products that cater to various medical needs. Their commitment to quality and compliance sets them apart in a competitive market, positioning them as a trusted name in the industry. With a robust market presence and a dedication to advancing cannabis research, InterCure Ltd. continues to shape the future of medical cannabis, making substantial contributions to patient care and wellness.

DitchCarbon Score

How does InterCure Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

InterCure Ltd.'s score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

InterCure Ltd.'s reported carbon emissions

InterCure Ltd., headquartered in Israel (IL), currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their carbon footprint in terms of kg CO2e across Scope 1, 2, or 3 emissions. While the company has not disclosed any climate commitments or initiatives aimed at reducing emissions, it is essential for organisations in the industry to establish clear sustainability goals and engage in practices that contribute to climate action. Without specific data or commitments, it is challenging to assess InterCure Ltd.'s impact on climate change or their alignment with global sustainability standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. InterCure Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for InterCure Ltd. is in IL, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

InterCure Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aurora Cannabis Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Cronos Group Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

IMCC

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers